B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 8.25 HKD -2.02% Market Closed
Market Cap: 3.3B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Biocytogen Pharmaceuticals Beijing Co Ltd
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biocytogen Pharmaceuticals Beijing Co Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Inventory
ÂĄ89.1m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Inventory
ÂĄ3B
CAGR 3-Years
72%
CAGR 5-Years
92%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Inventory
ÂĄ690.4m
CAGR 3-Years
-14%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Inventory
ÂĄ905.5m
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Inventory
ÂĄ15.7B
CAGR 3-Years
33%
CAGR 5-Years
43%
CAGR 10-Years
57%
Imeik Technology Development Co Ltd
SZSE:300896
Inventory
ÂĄ49.8m
CAGR 3-Years
23%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

Biocytogen Pharmaceuticals Beijing Co Ltd
Glance View

Market Cap
3.3B HKD
Industry
Biotechnology

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing. The company went IPO on 2022-09-01. The firm operates two business segments. The Drug Development Business segment is mainly engaged in the research and development of oncology and autoimmune disease treatments, as well as antibody development. The Preclinical Research Service segment is mainly engaged in gene editing, preclinical pharmacological efficacy evaluation and model animal sales.

Intrinsic Value
11.01 HKD
Undervaluation 25%
Intrinsic Value
Price
B

See Also

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Inventory?
Inventory
89.1m CNY

Based on the financial report for Dec 31, 2023, Biocytogen Pharmaceuticals Beijing Co Ltd's Inventory amounts to 89.1m CNY.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Inventory growth rate?
Inventory CAGR 3Y
13%

Over the last year, the Inventory growth was -6%. The average annual Inventory growth rates for Biocytogen Pharmaceuticals Beijing Co Ltd have been 13% over the past three years .

Back to Top